1α,25-dihydroxyvitamin D3 displays divergent growth effects in both normal and malignant cells
- 1 May 2001
- Vol. 66 (3-5) , 433-440
- https://doi.org/10.1016/s0039-128x(00)00203-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- 24R,25-Dihydroxyvitamin D3: An Essential Vitamin D3 Metabolite for Both Normal Bone Integrity and Healing of Tibial Fracture in ChicksEndocrinology, 1997
- Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherinJournal of Molecular Endocrinology, 1997
- Stimulation versus Inhibition of Keratinocyte Growth by 1,25-Dihydroxyvitamin D3: Dependence on Cell Culture ConditionsJournal of Investigative Dermatology, 1996
- Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.Genes & Development, 1996
- Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cellsEndocrinology, 1994
- The effects of 1,25-dihydroxyvitamin D3 on osteoclast formation in fetal mouse metatarsal organ culturesBone, 1994
- Bone and haematopoietic defects in mice lacking c-fosNature, 1992
- Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells.Journal of Clinical Investigation, 1986
- Induction of c-fos during myelomonocytic differentiation and macrophage proliferationNature, 1985
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981